Annual Accounts Receivable
$5.34 M
+$4.64 M+662.43%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual accounts receivable is $5.34 million, with the most recent change of +$4.64 million (+662.43%) on March 31, 2024.
- During the last 3 years, IMVT annual accounts receivable has risen by +$4.74 million (+795.47%).
- IMVT annual accounts receivable is now -56.36% below its all-time high of $12.23 million, reached on March 31, 2022.
Performance
IMVT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$2.22 M
+$348.00 K+18.55%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly accounts receivable is $2.22 million, with the most recent change of +$348.00 thousand (+18.55%) on December 31, 2024.
- Over the past year, IMVT quarterly accounts receivable has increased by +$1.20 million (+116.13%).
- IMVT quarterly accounts receivable is now -83.12% below its all-time high of $13.18 million, reached on June 30, 2022.
Performance
IMVT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IMVT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +662.4% | +116.1% |
| 3 y3 years | +795.5% | - |
| 5 y5 years | - | - |
IMVT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.4% | +795.5% | -83.1% | +217.7% |
| 5 y | 5-year | -56.4% | +795.5% | -83.1% | +273.1% |
| alltime | all time | -56.4% | +795.5% | -83.1% | +273.1% |
Immunovant Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $2.22 M(+18.6%) |
| Sep 2024 | - | $1.88 M(-22.4%) |
| Jun 2024 | - | $2.42 M(-54.7%) |
| Mar 2024 | $5.34 M | $5.34 M(+418.7%) |
| Dec 2023 | - | $1.03 M(-27.6%) |
| Sep 2023 | - | $1.42 M(+72.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $823.00 K(+17.6%) |
| Mar 2023 | $700.00 K(-94.3%) | $700.00 K(-0.6%) |
| Dec 2022 | - | $704.00 K(-81.4%) |
| Sep 2022 | - | $3.78 M(-71.3%) |
| Jun 2022 | - | $13.18 M(+7.8%) |
| Mar 2022 | $12.23 M(+1951.8%) | $12.23 M(+1951.8%) |
| Mar 2021 | $596.00 K | $596.00 K |
FAQ
- What is Immunovant annual accounts receivable?
- What is the all time high annual accounts receivable for Immunovant?
- What is Immunovant annual accounts receivable year-on-year change?
- What is Immunovant quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Immunovant?
- What is Immunovant quarterly accounts receivable year-on-year change?
What is Immunovant annual accounts receivable?
The current annual accounts receivable of IMVT is $5.34 M
What is the all time high annual accounts receivable for Immunovant?
Immunovant all-time high annual accounts receivable is $12.23 M
What is Immunovant annual accounts receivable year-on-year change?
Over the past year, IMVT annual accounts receivable has changed by +$4.64 M (+662.43%)
What is Immunovant quarterly accounts receivable?
The current quarterly accounts receivable of IMVT is $2.22 M
What is the all time high quarterly accounts receivable for Immunovant?
Immunovant all-time high quarterly accounts receivable is $13.18 M
What is Immunovant quarterly accounts receivable year-on-year change?
Over the past year, IMVT quarterly accounts receivable has changed by +$1.20 M (+116.13%)